Description:
A drug used to treat adults with extensive-stage small cell lung cancer that got worse during or after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Tarlatamab binds to a protein called CD3, which is found on T cells (a type of white blood cell). It also binds to a protein called DLL3, which is found on some types of cancer cells. This may help the immune system kill cancer cells. Tarlatamab is a type of bispecific T-cell engager. Also called Imdelltra.
